Preview

Нефрология

Расширенный поиск

СНИЖЕНИЕ СКОРОСТИ КЛУБОЧКОВОЙ ФИЛЬТРАЦИИ КАК НЕЗАВИСИМЫЙ ФАКТОР РИСКА СЕРДЕЧНО-СОСУДИСТОЙ БОЛЕЗНИ

https://doi.org/10.24884/1561-6274-2006-10-4-7-17

Полный текст:

Об авторах

А. В. Смирнов
Научно-исследовательский институт нефрологии Санкт-Петербургского государственного медицинского университета им. акад. И.П. Павлова
Россия
кафедры пропедевтики внутренних болезней, факультетской хирургии, нефрологии и диализа


В. М. Седов
Научно-исследовательский институт нефрологии Санкт-Петербургского государственного медицинского университета им. акад. И.П. Павлова
Россия
кафедры пропедевтики внутренних болезней, факультетской хирургии, нефрологии и диализа


Лхаахуу Од-Эрдэне
Научно-исследовательский институт нефрологии Санкт-Петербургского государственного медицинского университета им. акад. И.П. Павлова
Россия
кафедры пропедевтики внутренних болезней, факультетской хирургии, нефрологии и диализа


И. Г. Каюков
Научно-исследовательский институт нефрологии Санкт-Петербургского государственного медицинского университета им. акад. И.П. Павлова
Россия
кафедры пропедевтики внутренних болезней, факультетской хирургии, нефрологии и диализа


В. А. Добронравов
Научно-исследовательский институт нефрологии Санкт-Петербургского государственного медицинского университета им. акад. И.П. Павлова
Россия
кафедры пропедевтики внутренних болезней, факультетской хирургии, нефрологии и диализа


И. Ю. Панина
Научно-исследовательский институт нефрологии Санкт-Петербургского государственного медицинского университета им. акад. И.П. Павлова
Россия
кафедры пропедевтики внутренних болезней, факультетской хирургии, нефрологии и диализа


Список литературы

1. Lindner A, Charra B, Sherrard DJ. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697-701

2. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9: S16-S23

3. Dhingra H, Zaski ME. Outcomes research in dialysis. Semin Nephrol 2003; 23: 295-305

4. Cheung AK, Sarnak MJ, Jan G et al. Atherosclerotic cardiovascular disease in chronic hemodialysis patients. Kidney Int 2000; 58: 353-362

5. Joki N, Hase H, Nakamura R, Jamaguchi T. Onset of coronary artery disease prior to initiation of hemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 1997; 12: 718-723

6. Смирнов АВ, Козлов ВВ. Клинические проявления атеросклероза у больных на гемодиализе. Нефрология 1998; 2(2): 68-77

7. Jungers P, Massy Z, Khoa T et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 1997; 12: 2597-2602

8. Shoji T, Emoto M, Tabata T et al. Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int 2002; 61: 2187-2192

9. Руденко ТЕ, Кутырина ИМ, Кушнир ВВ, Швецов МЮ. Факторы, влияющие на состояние комплекса интима-медиа сонных и бедренных артерий в начальных стадиях хронической почечной недостаточности. Тер арх 2005; (6): 46-50

10. Mann JFE, Gerstein HC, Pogue J et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Int Med 2001; 134: 629-636

11. McClellan WM, Langston RD, Presley R. Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease. J Am Soc Nephrol 2004; 15: 1912-1919

12. Al-Ahmat A, Hand WM, Maanjuna G et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Col Cardiol 2001; 38: 955-962

13. Shlipak MG, Smith GZ, Rathore SS et al. Renal function, digoxin therapy, and heart failure outcomes: Evidence from the digoxin intervention group trial. J Am Soc Nephro l2004; 15: 2195-2203

14. Anavekar NS, McMurray JJ, Velazguez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351:1285-1295

15. Hillege HZ, Girbes AR, de Kam PF et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102: 203-210

16. Hillege HZ, van Gilst WH, van Veldhuisen DJ et al. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of AGE inhibition: the CATS randomized trial. Eur Heart J 2003; 24: 412-420

17. McCullough PA, Soman SS, Shah SS et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Col Cardiol 2000; 36: 679-684

18. Shlipak M, Heidenreich PA, Noguchi H et al. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002; 137: 555-562

19. Wright SR, Reeder GS, Herzog CH et al. Acute myocardial infarction and renal dysfunction: a high risk combination. Ann Intern Med 2002; 137: 563-570

20. Jones CA. Hypertension and renal dysfunction: NHANES III. J Am Soc Nephrol 2003; 14: S71-S75

21. Segura J, Campo C, Gil P et al. Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients. J Am Soc Nephrol 2004; 15: 1616-1622

22. Wannamethee SG, Shaper AG, Perry IJ. Serum creatinine concentration and risk of cardiovascular disease: A possible marker of increased risk for stroke. Stroke 1997; 28: 557-563

23. Seliger SZ, Siscovick DS, Stehman-Breen CO et al. Moderate renal impairment and risk of dementia among older adults: the cardiovascular health cognition study. J Am Soc Nephrol 2004; 15: 1904-1911

24. Rahman M, Brown CD, Coresh J et al. The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the antihypertensive and lipid-lowering treatment to patients heart attack trial. Arch Intern Med 2004; 164: 969-976

25. National Kidney Foundation KD: Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002; 39 [Suppl 1]: S1-S266

26. Смирнов АВ, Есаян АМ, Каюков ИГ. Хроническая болезнь почек: на пути к единству представлений. Нефрология 2002; 6(4): 11-17

27. Смирнов АВ, Каюков ИГ, Есаян АМ, Добронравов ВА, Кучер АГ, Тугушева ФА. Превентивный подход в современной нефрологии. Нефрология 2004; 8(3): 7-14

28. Vanholder R, Massy Z, Argiles A et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20: 1048-1056

29. Reddan DN, Szczech LA, Tuttb RH. Chronic kidney disease, mortality and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol 2003; 14: 2373-2380

30. Manjunath G, Tighiouart H, Coresh et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003; 63: 1121-1129

31. Culleton BF, Larson MG, Evans JC et al. Prevalence and correlates of elevated serum creatinine levels: the framingham heart study. Arch Intern Med 1999; 159: 1785-1790

32. Nissenson AR, Pereira BJ, Colling AJ, Steinberg EP. Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organization. Am J Kidney Dis 2001; 37: 1177-1183

33. Jones CA, McQuillan GM, Kusek JW et al. Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 1998; 32: 992-999

34. Clase CM, Garg AX, Kiberd BA. Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES-III). J Am Soc Nephrol 2002; 13: 1338-1349

35. Nitsch D, Dietrich DF, von Eckardstein A et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPAZDIA study. Nephrol Dial Transplant 2006; 21: 935-944

36. Ninomija T, Kiyohara J, Kubo M et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama study. Kidney Int 2005; 68: 228-236

37. Добронравов ВА, Смирнов АВ, Драгунов СВ и др. Эпидемиология хронической болезни почек в Вологодской области. Нефрология 2004; 8(1): 36-41

38. Добронравов ВА, Смирнов АВ, Драгунов СВ и др. Эпидемиология хронической почечной недостаточности в Северо-Западном регионе России: на пути к созданию регистра хронической почечной болезни. Тер арх 2004; 76(9): 57-61

39. Смирнов АВ, Добронравов ВА, Бодур-Ооржак АШ и др. Эпидемиология и факторы риска хронических болезней почек: региональный уровень общей проблемы. Тер арх 2005; (6): 20-27

40. Смирнов АВ, Добронравов ВА, Бодур-Ооржак АШ и др. Распространенность и заболеваемость поздними стадиями хронической болезни почек в Республике Тыва. Нефрология 9(4): 25-29

41. Culleton BF, Larson MG, Wilson PWF et al. Cardiovascular disease and mortality in a community based cohort with mild renal insufficiency. Kidney Int 1999; 56: 2214-2219

42. Garg AX, ClaarkWF, Haynes B, House AA. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES-I. Kidney Int 2002; 61: 1486-1494

43. Wali RK, Henrich WL. Chronic kidney disease: a risk factor for cardiovascular disease. Cardiol Clin 2005; 23, 3: 343-362

44. Munter P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent dealt resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002; 13: 745-753

45. Anderson S, Brenner BM. Effects of aging on the renal glomerulus. Am J Med 1983; 80: 435-442

46. Shlipak MG, Fried LF, Crump C et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int 2002; 62(3):997-1004

47. Weiner DE, Tighionart H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315

48. Henry RMA, Kostense PJ, Bos G et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the horn study. Kidney Int 2002; 62: 1402-1407

49. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470

50. Wang JG, Staessen JA, Fagard RH et al. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 2001; 37: 1069-1074

51. Friedman PJ. Serum creatinine: an independent predictor of survival after stroke. Intern Med 1991; 229: 175-179

52. Bursztyn M, Ginsberg G, Spilberg O et al. Mortality in the Jerusalem 70-year-olds longitudinal study: does nifedipine have a role? Geriatr Nephrol Urol 1999; 9:5-10

53. Shlipak MG, Sarnak MJ, Katz R et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049-2060

54. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305

55. Shlipak MG, Fried LF, Cushman M et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005; 293:1737-1745

56. White SZ, Cass A, Atkins RG, Chadban SJ. Chronic kidney disease in the general population. Adv Chronic Kidney Dis 2005; 12: 5-13

57. Trivedi HS, Pang MMH, Campbell A, Saab P. Slowing the progression of chronic renal failure: economic benefits and patients perspectives. Am J Kidney Dis 2002; 39:721-729

58. Duncan L, Heathcote J, Djurdjev O, Levin A. Screening for renal disease using serum creatinine: who are we missing? Nephrol Dial Transplant 2001; 16: 1042-1046

59. Amann K, Ritz C, Adameza KM, Ritz E. Why is coronary heart disease of uraemic patients so frequent and so devastating? Nephrol Dial Transplant 2003; 18: 631-640

60. Chobanian A, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The JNC-7 Report. JAMA 2003; 289: 2560-2572


Для цитирования:


Смирнов А.В., Седов В.М., Од-Эрдэне Л., Каюков И.Г., Добронравов В.А., Панина И.Ю. СНИЖЕНИЕ СКОРОСТИ КЛУБОЧКОВОЙ ФИЛЬТРАЦИИ КАК НЕЗАВИСИМЫЙ ФАКТОР РИСКА СЕРДЕЧНО-СОСУДИСТОЙ БОЛЕЗНИ. Нефрология. 2006;10(4):7-17. https://doi.org/10.24884/1561-6274-2006-10-4-7-17

For citation:


Smirnov A.V., Sedov V.M., Od-Erdene L., Kayukov I.G., Dobronravov V.A., Panina I.Yu. REDUCTION OF THE GLOMERULAR FILTRATION RATE AS AN INDEPENDENT RISK FACTOR OF THE CARDIO-VASCULAR DISEASE. Nephrology (Saint-Petersburg). 2006;10(4):7-17. (In Russ.) https://doi.org/10.24884/1561-6274-2006-10-4-7-17

Просмотров: 64


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)